SVE.WA
Price:
$3.85
Market Cap:
$271.04M
Synthaverse S.A., a pharmaceutical company, manufactures and sells medicinal products, medical devices, and laboratory reagents in Poland. The company's prescription drugs include Distreptaza, a medication used in gynecology for treating chronic inflammatory disease of the uterine appendages and hemorrhoids; Onko BCG 50 and BCG 100 products for treating superficial (non-muscle invasive) bladder tumor; GAMMA anty HBs 200 medications for passive immunization against hepatitis B; GAMMA anty-D 50 and GAMMA anty-D 150, which are Anti D (Rho) immunoglobulin products used in prevention of hemolytic disease of the foetus and newborn; BioTrombina 400, a medication for topical control of severe bleedi...[Read more]
Industry
Biotechnology
IPO Date
2011-07-29
Stock Exchange
WSE
Ticker
SVE.WA
According to Synthaverse S.A.’s latest financial reports and current stock price. The company's current ROE is 6.31%. This represents a change of 310.09% compared to the average of 1.54% of the last 4 quarters.
The mean historical ROE of Synthaverse S.A. over the last ten years is -233.35%. The current 6.31% ROE has changed -102.70% with respect to the historical average. Over the past ten years (40 quarters), SVE.WA's ROE was at its highest in in the December 2017 quarter at 21.22%. The ROE was at its lowest in in the December 2016 quarter at -934.07%.
Average
-233.35%
Median
4.96%
Minimum
-2083.05%
Maximum
11.90%
Discovering the peaks and valleys of Synthaverse S.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.02%
Maximum Annual ROE = 11.90%
Minimum Annual Increase = -65399.59%
Minimum Annual ROE = -2083.05%
| Year | ROE | Change |
|---|---|---|
| 2024 | 6.22% | 47.14% |
| 2023 | 4.22% | -26.67% |
| 2022 | 5.76% | 1.08% |
| 2021 | 5.70% | -52.10% |
| 2020 | 11.90% | 57.50% |
| 2019 | 7.55% | -107.09% |
| 2018 | -106.62% | -10581.97% |
| 2017 | 1.02% | -100.05% |
| 2016 | -2083.05% | 1.02% |
| 2015 | -186.17% | -65399.59% |
The current ROE of Synthaverse S.A. (SVE.WA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
5.40%
5-year avg
6.76%
10-year avg
-233.35%
Synthaverse S.A.’s ROE is greater than Bioton S.a. (-1.76%), greater than Captor Therapeutics Spolka Akcyjna (-77.21%), greater than Molecure S.A. (-32.20%), greater than Medicalgorithmics S.A. (-20.71%), greater than Mabion S.A. (-32.43%), greater than Poltreg S.A. (-37.19%), greater than Bioceltix S.A. (-36.36%), greater than Pharmena S.A. (-15.06%), less than Mercator Medical S.A. (2.69%), greater than NanoGroup S.A. (-57.44%),
| Company | ROE | Market cap |
|---|---|---|
| -1.76% | $343.46M | |
| -77.21% | $383.67M | |
| -32.20% | $150.20M | |
| -20.71% | $344.37M | |
| -32.43% | $130.11M | |
| -37.19% | $111.46M | |
| -36.36% | $427.43M | |
| -15.06% | $34.08M | |
| 2.69% | $352.99M | |
| -57.44% | $90.06M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synthaverse S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Synthaverse S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Synthaverse S.A.'s ROE?
How is the ROE calculated for Synthaverse S.A. (SVE.WA)?
What is the highest ROE for Synthaverse S.A. (SVE.WA)?
What is the 3-year average ROE for Synthaverse S.A. (SVE.WA)?
What is the 5-year average ROE for Synthaverse S.A. (SVE.WA)?
How does the current ROE for Synthaverse S.A. (SVE.WA) compare to its historical average?